Therapeutic Solutions International Inc (TSOI): TSOI makes the drug with bio molecules (...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Therapeutic Solutions International Inc (TSOI)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	37
Posts	2733
Boards Moderated	0
Alias Born	04/22/2019

Re: None

Monday, 10/14/2019 6:51:19 AM

Monday, October 14, 2019 6:51:19 AM

TSOI makes the drug with bio molecules (no chemical moelcules) which not only decreases side effects but also increases the patients immunity against cancer. Moreover increasingly there is push from patients and pharma companies to have life force energy enabled compound into the next generation of DRUGS to fight the deadly acute diseases. Even the BIG PHARMA will have their eyes wide open to have look at the clinical trial results so that they can SNAP up TSOI ASAP. just my humble opinion.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TSOI News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:29:10 PM

More TSOI News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow